Publication

Section I: Contracting authority

I.1)

Name and addresses

University Hospitals of North Midlands NHS Trust

N/A

Royal Stoke University Hospital, Newcastle Road

Stoke on Trent, Staffordshire

ST4 6QG

UK

Contact person: Leah Meakin

Telephone: +44 1782676319

E-mail: Leah.Meakin@uhnm.nhs.uk

Internet address(es):

Main address: www.uk.eu-supply.com/ctm/Supplier/CompanyInformation/Index/13355

Address of the buyer profile: https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/13355

I.2)

Joint procurement

The contract is awarded by a central purchasing body

I.3)

Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at:

https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=31051&B=UHNS

Additional information can be obtained from

the abovementioned address:

Tenders or requests to participate must be submitted

electronically via: https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=31051&B=UHNS

Tenders or requests to participate must be submitted

to the abovementioned address

I.4)

Type of the contracting authority

Other type: NHS

I.5)

Main activity

Health

Section II: Object

II.1)

Scope of the procurement

II.1.1)

Title

Supply of Radium 223 Treatment - MED3304

Reference number: Radium 223 - MED3304

II.1.2)

Main CPV code

09344000 - Radio-isotopes

II.1.3)

Type of contract

Supplies

II.1.4)

Short description

Supply of Radium 223 Dichloride for treating hormone - relapsed Prostate Cancer with bone metastases (TA376) to the University Hospitals of North Midlands NHS Trust. For a period of 2 Years initially with the option to extend 2 x 12 month periods.

II.1.5)

Estimated total value

Value excluding VAT: 13000000.00 GBP

II.1.6)

Information about lots

This contract is divided into lots: no

II.2)

Description

II.2.2)

Additional CPV code(s)

09344000 - Radio-isotopes

II.2.3)

Place of performance

Main site or place of performance:

UHNM, Stoke on Trent, Staffordshire

II.2.4)

Description of the procurement

The Trust is seeking Bid Proposals in order to establish a 2 year Contract with the option to extend 2 x 12 months with a single Provider to supply NICE approved Radium 223 Injections.
Radium 223 Dichloride supplied as a licensed therapeutic alpha-emitting solution for intravenous injection for the treatment of adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.
Supplied in a form suitable for the administration of 55 kBq per kg body weight, with the anticipation that the administration will be repeated at an interval of four weeks for a total of six injections per patient.
This product should only be delivered between 9am - 5pm Monday - Friday (excluding Bank Holidays) to the University Hospitals of North Midlands NHS Trust. Due to the nature of radioactive decay each vial is ordered for a set date of injection for a specific body weight.
Anticipated usage is sufficient for:
Year 1 - 25 patients per year (i.e: up to 150 injections per year)
Year 2 – 40 patients year (i.e. up to 240 injections per year)
Year 3 (extension year 1) – 40 patients year (i.e. up to 240 injections per year)
Year 4 (extension year 2) – 40 patients year (i.e. up to 240 injections per year)
The successful Supplier will have a fully Licensed Radium 223 drug which is approved and funded by NICE.
The announcement of a possible future requirement is not to be construed as confirmation that a Contract will subsequently be issued. The issue of a possible future requirement, or the issue of an Invitation to Tender, is not to be construed as a firm commitment by the Authority to place an order as a result of the tendering stage or at a later stage. Any expenditure, work or effort prior to any Contract award is accordingly a matter solely for the commercial judgment of the tenderer.

II.2.5)

Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6)

Estimated value

Value excluding VAT: 13000000.00 GBP

II.2.7)

Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 48

This contract is subject to renewal: no

II.2.10)

Information about variants

Variants will be accepted: no

II.2.11)

Information about options

Options: yes

Description of options:

2 Years period with option to extend for 2 x 12 months

II.2.13)

Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

Section III: Legal, economic, financial and technical information

III.1)

Conditions for participation

III.1.1)

Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

List and brief description of conditions: Selection criteria as stated in the procurement documents

III.1.2)